Article
A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer
28 Feb 2024
Abstract excerpt
The clinical impact of tumor-specific neoantigens as both immunotherapeutic targets and biomarkers has been impeded by the lack of efficient methods for their identification and validation from routine samples. We have developed a platform that combines bioinformatic analysis of tumor exomes and transcriptional data with functional testing of autologous peripheral blood mononuclear cells (PBMCs) to simultaneously...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
